ангиопоетин-1 在内毒性休克中具有保护作用
Bernhard Witzenbichler1, Dirk Westermann, Sabine Knueppel
1Department of Cardiology and Pneumology, Universitätsmedizin Berlin, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. b.witzenbichler@gmx.de
Circulation
|December 22, 2004
概括
通过稳定血液动力学功能和减少肺损伤,angiopoietin-1 (Ang1) 治疗改善了内毒性休克小鼠的生存率. 这表明Ang1可能是治疗败血症休克的有价值的辅助疗法.
科学领域:
- 血管生物学 血管生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- ангиопоетин-1 (Ang1) 对于血管发育和稳定性至关重要.
- Ang1具有抗炎性质,对涉及微血管泄漏的疾病有益.
研究的目的:
- 为了研究Ang1的治疗潜力,在LPS诱导的内毒性休克的小鼠模型中研究Ang1.
- 评估Ang1对血液动力学功能,器官损伤和生存的影响.
主要方法:
- 在使用LPS的小鼠中诱导了内毒性休克.
- 治疗小鼠时使用表达Ang1 (AdhAng1) 的腺病毒结构或控制载体 (AdGFP).
- 评估了血液动力学参数,生存率,肺损伤标志物和炎症分子表达.
主要成果:
- 与对照组相比,AdhAng1治疗保留了血液动力学功能,并显著改善了生存率.
- Ang1的使用减少了LPS引起的肺损伤,包括肺水含量降低和髓氧化酶活性降低.
- 在AdhAng1治疗的小鼠中,炎症粘附分子的表达较低,内皮氧化合成酶 (eNOS) 活性被保留.
结论:
- 通过改善血液动力学稳定性和减轻器官损伤,Ang1的使用可以提高内毒性休克的生存率.
- Ang1治疗减少了炎症反应,并保持了eNOS活性,这表明它在败血症休克中起着保护作用.
- ангиопоетин-1 显示出作为治疗性休克的辅助治疗剂的前景.
更多相关视频
08:36The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
相关概念视频
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...